A detailed history of Dunhill Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dunhill Financial, LLC holds 643 shares of LLY stock, worth $503,578. This represents 0.29% of its overall portfolio holdings.

Number of Shares
643
Previous 559 15.03%
Holding current value
$503,578
Previous $506 Million 12.56%
% of portfolio
0.29%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $64,859 - $80,641
84 Added 15.03%
643 $570 Million
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $205,863 - $258,167
-284 Reduced 33.69%
559 $506 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 0.84%
843 $655 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $439,058 - $517,592
836 New
836 $487 Million
Q2 2023

Aug 23, 2023

BUY
$350.74 - $468.98 $284,099 - $379,873
810 New
810 $447 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.